Literature DB >> 23220892

Combined categorical reporting systems of US and cytology findings for thyroid nodules: guidance on repeat fine-needle aspiration cytology.

Sang-Woo Lee1, Hui Joong Lee, Hye Jung Kim, Jongmin Lee, Ji-Young Park, Seong Hun Kim, Junghun Kim.   

Abstract

PURPOSE: To investigate the usefulness of the combined categorical reporting system of ultrasonography (US) and cytology results for thyroid nodules to suggest indications of repeat US-guided fine needle aspiration cytology (FNAC).
MATERIALS AND METHODS: Institutional review board approval was obtained, and the requirement for informed consent was waived for this retrospective study. From June 2001 to December 2009, 1084 patients (978 women, 106 men) who underwent repeat US-guided FNAC of thyroid nodules were included. FNAC results were reported by using the Bethesda system for reporting thyroid cytopathologic findings and five thyroid US categories (category US 1, benign; US 2, probably benign; US 3, indeterminate; US 4, probably malignant; US 5, malignant). The relative risk ratios were evaluated in each separate FNAC and combined initial category by means of Cox proportional risk model.
RESULTS: Eighty-one of 1084 (7.5%) patients had malignancy over a mean follow-up time of 20.8 months (range, 3-98 months). Initial FNAC category of atypia of undetermined significance (relative risk ratio, 9.677) and US categories of US 3 (28.76), US 4 (142.0), and US 5 (411.6) had high relative risk ratios for malignancy (P < .05). Combined categories of benign cytology findings with US 3-5, nondiagnostic cytology findings with US 3-5, and atypia of undermined significance with any US categorization had high relative risk ratios of 104.80 (95% confidence interval: 53.328, 205.966).
CONCLUSION: The combination of the categorical reporting systems between cytology and US results could be useful to suggest indications of repeat US-guided FNAC.

Entities:  

Mesh:

Year:  2012        PMID: 23220892     DOI: 10.1148/radiol.12112710

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Cancer: Indeterminate thyroid nodules--added testing, added value?

Authors:  Jin Young Kwak; Eun-Kyung Kim
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

2.  Thyroid cancers with benign-looking sonographic features have different lymph node metastatic risk and histologic subtypes according to nodule size.

Authors:  Dong Yeob Shin; Young Ki Lee; Kwang Joon Kim; Kyeong Hye Park; Sena Hwang; Se Hee Park; Eun-Kyung Kim; Hyeong Ju Kwon; Eun Jig Lee
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

3.  Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.

Authors:  Oya Topaloglu; Husniye Baser; Fatma Neslihan Cuhaci; Nuran Sungu; Abdussamed Yalcin; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2016-05-12       Impact factor: 3.633

4.  Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.

Authors:  Husniye Baser; Oya Topaloglu; Abbas Ali Tam; Berna Evranos; Afra Alkan; Nuran Sungu; Ersin Gurkan Dumlu; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2016-03-14       Impact factor: 3.633

5.  Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?

Authors:  Mi Ri Yoo; Hye Mi Gweon; Ah Young Park; Kyung Eun Cho; Jeong-Ah Kim; Ji Hyun Youk; Eun Ju Son
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

6.  Benign Aspirates on Follow-Up FNA May Be Enough in Patients with Initial Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance.

Authors:  Ga Ram Kim; Jung Hyun Yoon; Eun-Kyung Kim; Hee Jung Moon; Jin Young Kwak
Journal:  Int J Endocrinol       Date:  2014-02-13       Impact factor: 3.257

7.  Risk stratification of thyroid nodules with Bethesda category III results on fine-needle aspiration cytology: The additional value of acoustic radiation force impulse elastography.

Authors:  Chong-Ke Zhao; Hui-Xiong Xu; Jun-Mei Xu; Cheng-Yu Sun; Wei Chen; Bo-Ji Liu; Xiao-Wan Bo; Dan Wang; Shen Qu
Journal:  Oncotarget       Date:  2017-01-03

8.  Thyroid nodules with minimal cystic changes have a low risk of malignancy.

Authors:  Dong Gyu Na; Ji-Hoon Kim; Dea Sik Kim; Soo Jin Kim
Journal:  Ultrasonography       Date:  2015-12-15

9.  The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology.

Authors:  So Yoon Park; Soo Yeon Hahn; Jung Hee Shin; Eun Young Ko; Young Lyun Oh
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

10.  Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype.

Authors:  Won Sang Yoo; Hwa Young Ahn; Hye Shin Ahn; Yun Jae Chung; Hee Sung Kim; Bo Youn Cho; Mirinae Seo; Jae Hoon Moon; Young Joo Park
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.